Why I'm telling friends to avoid gold stocks

Back in November, gold made a tiny move of 1.6%. But according to my backtesting by using a special type of gold trade, I would have seen a 141% gain in just a week. It happened again in March. Gold nudged up 1.2%. This time? A 104% overnight gain. And in June? A 1% gold move turned into a 74% gain in two weeks. Granted, there would have been smaller wins and those that did not work out, but you see, there's a reason I'm telling all my friends to hold off from buying gold or regular gold stocks right now. There's a more lucrative way to play the gold market as we enter a new breakout period. It's all about catching what I call "Acceleration Cycles."

And if you’d like to get your hands on this, here you go, the complete breakdown.

Jonathan Olefson net worth and biography

Jonathan Olefson Biography and Net Worth

General Counsel of Syneos Health

Oversees the global legal function, including the Legal, Compliance and Corporate Quality teams; and the Assistant Corporate Secretary

Brings extensive expertise in data analytics, Intellectual Property and global markets, as well as a significant understanding of the consulting and healthcare industries

Previously served as the General Counsel and Secretary of Cotiviti Holdings, where he led the development of the company’s Legal, Compliance and Government Relations departments in preparation for its transition from a private equity portfolio company to being publicly traded on the NYSE

Has significant experience in corporate development, mergers and acquisitions, and private equity backed public companies through his tenures with Cotiviti Holdings and Cognizant Technology Solutions, where he served as Vice President and General Counsel and held leadership positions including Chief Intellectual Property Counsel and Lead Attorney for Corporate Development and M&A

Juris Doctor, The George Washington University Law School; Bachelor of Arts in Political Science, Emory University

What is Jonathan Olefson's net worth?: The estimated net worth of Jonathan Olefson is at least $1.09 million as of July 20th, 2022. Mr. Olefson owns 25,292 shares of Syneos Health stock worth more than $1,087,050 as of December 18th. This net worth approximation does not reflect any other assets that Mr. Olefson may own. Additionally, Mr. Olefson receives an annual salary of $526,130.00 as General Counsel at Syneos Health. Learn More about Jonathan Olefson's net worth.
How old is Jonathan Olefson?: Mr. Olefson is currently 47 years old. There are 6 older executives and no younger executives at Syneos Health. The oldest executive at Syneos Health is Ms. Michelle Keefe, CEO, Non-Executive Director and Advisor, who is 56 years old. Learn More on Jonathan Olefson's age.
What is Jonathan Olefson's salary?: As the General Counsel of Syneos Health, Inc., Mr. Olefson earns $526,130.00 per year. There are 3 executives that earn more than Mr. Olefson. The highest earning executive at Syneos Health is Ms. Michelle Keefe, CEO, Non-Executive Director and Advisor, who commands a salary of $876,280.00 per year. Learn More on Jonathan Olefson's salary.
How do I contact Jonathan Olefson?: The corporate mailing address for Mr. Olefson and other Syneos Health executives is 1030 Sync Street, Morrisville NC, 27560. Syneos Health can also be reached via phone at (919) 876-9300 and via email at [email protected]. Learn More on Jonathan Olefson's contact information.
Has Jonathan Olefson been buying or selling shares of Syneos Health?: Jonathan Olefson has not been actively trading shares of Syneos Health during the past quarter. Most recently, Jonathan Olefson sold 2,215 shares of the business's stock in a transaction on Wednesday, July 20th. The shares were sold at an average price of $75.00, for a transaction totalling $166,125.00. Following the completion of the sale, the general counsel now directly owns 25,292 shares of the company's stock, valued at $1,896,900. Learn More on Jonathan Olefson's trading history.
Who are Syneos Health's active insiders?: Syneos Health's insider roster includes Michael Brooks (Insider), John Dineen (Director), Linda Harty (Director), Michelle Keefe (CEO, Non-Executive Director and Advisor), Donna Kralowetz (CAO), Alistair Macdonald (CEO), John Maldonado (Director), Jason Meggs (CFO), Matthew Monaghan (Director), and Jonathan Olefson (General Counsel). Learn More on Syneos Health's active insiders.

Jonathan Olefson Insider Trading History at Syneos Health

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
7/20/2022	Sell	2,215	$75.00	$166,125.00	25,292
12/23/2021	Sell	1,889	$100.95	$190,694.55
3/29/2021	Sell	4,000	$77.00	$308,000.00	24,725
1/25/2021	Sell	5,336	$75.68	$403,828.48	27,214
12/17/2018	Buy	750	$41.27	$30,952.50

Jonathan Olefson Buying and Selling Activity at Syneos Health

Syneos Health Company Overview

Syneos Health, Inc., operates as an integrated biopharmaceutical solutions company. The company operates through two segments, Clinical Solutions and Commercial Solutions. The Clinical Solutions segment offers services for the development of diagnostics, drugs, biologics, devices, and digital therapeutics in Phase I to IV of clinical development. This segment offers individual services, including regulatory consulting, project management, protocol development, investigational site recruitment, clinical monitoring, technology-enabled patient recruitment and engagement, clinical home health services, clinical trial diversity, biometrics, and regulatory affairs. The Commercial Solutions segment provides commercialization services, including deployment solutions, communications solutions, such as public relations, advertising, and medical communication; and consulting services. Its customers include companies in the biopharmaceutical, biotechnology, and medical device industries. It operates in North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. The company has a strategic partnership with uMotif Limited to deliver patient-centric eClinical platform. The company was formerly known as INC Research Holdings, Inc. and changed its name to Syneos Health, Inc. in January 2018. Syneos Health, Inc. was incorporated in 2010 and is headquartered in Morrisville, North Carolina. As of September 28, 2023, Syneos Health, Inc. was taken private.

Today's Range

Now: $42.98

$42.97

$42.99

50 Day Range

MA: $42.86

$42.48

$42.98

2 Week Range

Now: $42.98

$22.89

$52.23

Volume

7,386,200 shs

Average Volume

1,924,736 shs

Market Capitalization

$4.46 billion

P/E Ratio

62.29

Dividend Yield

N/A

Beta

1.58

Why I'm telling friends to avoid gold stocks

From DTI | Ad